Effect estimate for different sets of subjects, HRs from Cox models and ORs from logistic models and corresponding 95% CIs for several outcomes
| Population not included (G1) | Included but not contacted (G2) | Included and contacted (G3) | |
| Overall mortality, n (%) | 4125 (0.83) | 3065 (3.87) | 641 (1.32) |
| HR* (95% CI) | 1# | 6.24 (5.88 to 6.61) | |
| 1# | 7.86 (7.40 to 8.35) | 3.14 (2.86 to 3.44) | |
| 1# | 0.39 (0.36 to 0.43) | ||
| OR** (95% CI) | 1# | 8.30 (7.79-8.83) | |
| 1# | 11.21 (10.47–12.01) | 3.89 (3.02–3.80) | |
| 1# | 0.33 (0.30–0.37) | ||
| COVID-19 morbidity, n (%) | 3889 (0.79) | 1942 (2.46) | 335 (0.69) |
| HR* (95% CI) | 1# | 2.94 (2.74 to 3.15) | |
| 1# | 1.42 (1.33 to 1.51) | 1.12 (0.99 to 1.26) | |
| 1# | 0.29 (0.26 to 0.32) | ||
| OR** (95% CI) | 1# | 2.81 (2.62 to 3.01) | |
| 1# | 3.73 (3.47 to 4.00) | 1.09 (0.96 to 1.23) | |
| 1# | 0.30 (0.27–0.34) | ||
| COVID-19 hospitalisation, n (%) | 3343 (0.67) | 1548 (1.96) | 298 (0.61) |
| HR* (95% CI) | 1# | 2.74 (2.54 to 2.95) | |
| 1# | 3.64 (3.37 to 3.94) | 1.14 (1.01 to 1.30) | |
| 1# | 0.32 (0.28 to 0.36) | ||
| OR** (95% CI) | 1# | 2.60 (2.41 to 2.80) | |
| 1# | 3.39 (3.14 to 3.67) | 1.11 (0.98 to 1.27) | |
| 1# | 0.34 (0.30 to 0.38) | ||
# Referencecategory